Spears Abacus Advisors LLC Astrazeneca PLC Transaction History
Spears Abacus Advisors LLC
- $4.64 Billion
- Q3 2025
A detailed history of Spears Abacus Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 3,333 shares of AZN stock, worth $297,970. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,333
Previous 2,981
11.81%
Holding current value
$297,970
Previous $208,000
22.6%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...